A detailed history of Cable Hill Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Cable Hill Partners, LLC holds 2,981 shares of MRNA stock, worth $196,000. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,981
Holding current value
$196,000
% of portfolio
0.04%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$101.21 - $166.61 $301,707 - $496,664
2,981 New
2,981 $353,000
Q3 2023

Oct 27, 2023

SELL
$96.41 - $126.61 $22,174 - $29,120
-230 Reduced 8.46%
2,490 $257,000
Q2 2023

Jul 19, 2023

SELL
$118.5 - $160.53 $17,656 - $23,918
-149 Reduced 5.19%
2,720 $330,000
Q1 2023

May 04, 2023

SELL
$135.66 - $197.02 $32,151 - $46,693
-237 Reduced 7.63%
2,869 $440,000
Q4 2022

Feb 06, 2023

BUY
$118.38 - $210.04 $8,286 - $14,702
70 Added 2.31%
3,106 $557,000
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $14,758 - $24,272
125 Added 4.29%
3,036 $359,000
Q2 2022

Aug 11, 2022

BUY
$117.13 - $176.59 $57,627 - $86,882
492 Added 20.34%
2,911 $416,000
Q1 2022

May 16, 2022

BUY
$126.46 - $235.05 $27,188 - $50,535
215 Added 9.75%
2,419 $417,000
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $451 - $737
-2 Reduced 0.09%
2,204 $560,000
Q3 2021

Nov 16, 2021

SELL
$221.9 - $484.47 $44,380 - $96,894
-200 Reduced 8.31%
2,206 $849,000
Q2 2021

Aug 13, 2021

SELL
$129.91 - $234.98 $28,060 - $50,755
-216 Reduced 8.24%
2,406 $565,000
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $32,317 - $55,050
296 Added 12.73%
2,622 $343,000
Q4 2020

Feb 09, 2021

BUY
$65.74 - $169.86 $152,911 - $395,094
2,326 New
2,326 $243,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.